Global Markets for Treatments for Syndromes of Progressive Ataxia and Weakness Disorders

Published - Oct 2012| Code - PHM118A| Publisher - BCC Publishing

Report Highlights

The global market for treatments for syndromes of progressive ataxia and weakness disorders was valued at nearly $14 billion in 2011 and should reach nearly $15 billion in 2012. Total market value is expected to reach nearly $23.5 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 9.4%.

SCOPE OF THE STUDY

The scope of this study encompasses the neurodegenerative (i.e., progressive ataxia and weakness) disorders in the pharmaceutical and biotechnology markets.  BCC analyzes each market and its applications, the regulatory environments, and the technologies involved, as well as market projections and market shares.  Technological issues include the latest trends and developments.  The emerging market for enzyme inhibitors includes such countries as India, China, Japan, South Korea, Taiwan, Canada, Africa, Australia and New Zealand.

Analyst Credentials

Shalini Shahani Dewan focuses on pharmaceuticals and biotechnology and has been a BCC Research contributor since 2002 as both an analyst and project manager. She has explored a wide range of topics and companies, including working for Johnson & Johnson doing market surveillance. She has an undergraduate degree in pharmacy and master's degree in medicinal chemistry. She resides in the Bay Area.

Latest reports include:

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter Name Pages Price Member Price
Full Report: Global Markets for Treatments for Syndromes of Progressive Ataxia and Weakness Disorders 170 $2,750 Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: EXECUTIVE SUMMARY2$250Free
Chapter- 3: OVERVIEW6$97Free
Chapter- 4: REGULATORY ASPECTS4$65Free
Chapter- 5: NEW DEVELOPMENTS8$129Free
Chapter- 6: GLOBAL MARKETS13$210Free
Chapter- 7: PROGRESSIVE ATAXIA SYNDROME MARKET27$437Free
Chapter- 8: PROGRESSIVE WEAKNESS SYNDROME MARKETS48$776Free
Chapter- 9: PATENT ANALYSIS13$210Free
Chapter- 10: CURRENT SITUATION6$97Free
Chapter- 11: COMPANY PROFILES37$599Free
Chapter- 12: APPENDIX I: ABBREVIATIONS3$49Free
RELATED REPORTS
Share This Report